Close Menu

Government-performed comparative drug studies are bad because the results not only affect Medicare but the private market as well, writes American Enterprise Institute fellow Scott Gottlieb in an op-ed for the Wall Street Journal. A provision for a new federal center to study the economics of drug choices (part of the State Children's Health Insurance Program) will give misleading results and the data will not be transparent, argues Gottlieb, drawing on past studies such as

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A German shepherd called Nala has had her genome sequenced.

A coronavirus serology test garners Emergency Use Authorization from the US Food and Drug Administration, but the Los Angeles Times asks: how will tests like that be used?

Certain gene variants in conjunction with a healthy lifestyle may keep brains young, according to New Scientist.

In Science this week: increased CD8 T cell density and increased IFN-gamma response may indicate metastatic prostate cancer patients who will respond to immune checkpoint blockade therapy.